By Steven Scheer JERUSALEM (Reuters) – MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers. The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or dead tissue from chronic wounds in